Delisting riskPopularity #3,598
Tenaya Therapeutics (TNYA)
Develops gene therapies and small molecules for genetically defined heart diseases.
$0.6811
After-hours close−0.01 (−1.28%)
At close$0.6899(+2.39%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | ≈ 24.12% | 54.08M shares | |
|---|---|---|---|
| 108 holders · as of Jun 30, 2026 · largest filers plus last quarter's tail | |||
| Insiders | 0.44% | 982.1K shares | |
| 4 holders · as of Sep 11, 2026 | |||
| Strategic holders | 5.90% | 13.23M shares | |
| 2 holders · as of Aug 24, 2026 | |||
| Other | ≈ 69.54% | 155.94M shares | |
| remainder | |||
224.23M company shares as of Sep 23, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
This quarter's institutional total failed a plausibility check; shown: the largest filers plus last quarter's remainder.
13F, as of Jun 30, 2026
108 holders · 54.08M shares · 20 new positions · 49 increased · 19 reduced · 20 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Vanguard Capital Management LLC | 7.10M | 3.17% | −1.38M | Aug 13, 2026 |
| Millennium Management LLC | 6.43M | 2.87% | +973.0K | Aug 14, 2026 |
| Citadel Advisors LLC | 4.57M | 2.04% | +366.8K | Sep 2, 2026 |
| Renaissance Technologies LLC | 4.28M | 1.91% | +567.3K | Aug 13, 2026 |
| BlackRock, Inc. | 4.01M | 1.79% | +304.8K | Aug 7, 2026 |
| Empery Asset Management, LP | 3.86M | 1.72% | −423.8K | Aug 11, 2026 |
| Marshall Wace, LLP | 3.50M | 1.56% | +797.8K | Aug 13, 2026 |
| Gsa Capital Partners LLP | 2.67M | 1.19% | +1.60M | Aug 6, 2026 |
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| TCG Opportunity III GP, LLCincl. The Column Group III, LP, Peter Svennilson +5 more | 23.10% | 49.31M | 13D | Feb 26, 2026 |
| Integrated Core Strategies (US) LLC | 5.20% | 11.58M | 13G | Aug 24, 2026 |
Form 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Aug 17, 2026 | Whittemore Tingleyofficer: Chief Medical Officer | Sale · 3 lots | 5,787 | $0.7098 | 214,073 |
| Aug 17, 2026 | Faraz Alidirector, officer: Chief Executive Officer | Sale · 4 lots | 22,232 | $0.7097 | 417,782 |
| May 18, 2026 | Tomohiro Higaofficer: SVP, Finance | Sale | 1,485 | $0.7932 | 118,267 |
| May 18, 2026 | Whittemore Tingleyofficer: Chief Medical Officer | Sale | 3,121 | $0.7936 | 215,497 |
| May 18, 2026 | Faraz Alidirector, officer: Chief Executive Officer | Sale | 3,390 | $0.7934 | 440,014 |
| Feb 25, 2026 | Column Group Iii GP, LP10 percent owner | Sale | 1,862,545 | $0.5624 | 0 |
| Feb 24, 2026 | Column Group Iii GP, LP10 percent owner | Sale · 2 lots | 658,440 | $0.6153 | 1,649,281 |
| Feb 23, 2026 | Column Group Iii GP, LP10 percent owner | Sale · 2 lots | 306,000 | $0.5972 | 1,958,509 |
| Feb 20, 2026 | Column Group Iii GP, LP10 percent owner | Sale · 2 lots | 523,734 | $0.6149 | 2,102,218 |
| Feb 17, 2026 | Whittemore Tingleyofficer: Chief Medical Officer | Sale · 2 lots | 3,518 | $0.6431 | 218,618 |
House and Senate disclosures
Not reported.